A feature of marked current interest in this volume is the preliminary report on alpha-dinitrophenol, the new drug for acceleration of cellular metabolism. The Council voices a warning on the dangers attending the use of this drug; this warning has been increasingly justified in reports of fatalities since the appearance of the Council's report in July of last year. Other preliminary reports which make this volume one of the most interesting issued by the Council in recent years are those on Dilaudid, a new narcotic drug related to morphine; Fuadin, a new antimony compound for use in the treatment of bilharziasis and granuloma inguinale, and Hippuran, a new product for intravenous and oral urography.
The comprehensive and definitive special report on estrogenic substances furnishes a much needed review of the present status of such products in gynecologic therapy. The Council insists on the doctrine that basic laboratory investigation of these